Pages that link to "Q72109576"

The following pages link to Patient age as a prognostic factor in prostate cancer (Q72109576):

Displaying 34 items.

• Prostate cancer: 2. Natural history. (Q34029755) (← links)
• Prostate cancer in young men: an important clinical entity. (Q34314644) (← links)
• Aging‐related alterations in the extracellular matrix modulate the microenvironment and influence tumor progression (Q34507732) (← links)
• Prognostic factors in prostate cancer (Q34682069) (← links)
• Neutrophil count is associated with survival in localized prostate cancer (Q35751637) (← links)
• Screening for prostate cancer: current recommendations (Q35763071) (← links)
• Hyaluronan in aged collagen matrix increases prostate epithelial cell proliferation (Q36064013) (← links)
• CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk (Q36619671) (← links)
• Does screening for prostate cancer identify clinically important disease? (Q36822054) (← links)
• Impact of age on clinical presentation, treatment, and cancer-specific survival of patients with small-cell carcinoma of the prostate (Q37027412) (← links)
• Prostate Cancer: How Young is too Young? (Q37743938) (← links)
• Prediction of significant cancer in men with stage Tic adenocarcinoma of the prostate (Q39458840) (← links)
• A quantitative analysis of the costs and benefits of prostate cancer screening (Q39638390) (← links)
• Correlations between age, Charlson score and outcome in clinical unilateral T3a prostate cancer (Q39864585) (← links)
• Impact of prostate-specific antigen screening on the natural history of prostate cancer (Q40383475) (← links)
• The socioeconomic implications of prostate-specific antigen screening (Q40896913) (← links)
• Management of prostate and bladder cancer in the elderly. (Q41013404) (← links)
• Surveillance is not a viable and appropriate treatment option in the management of localized prostate cancer (Q41249010) (← links)
• Is screening for prostate cancer the current gold standard?--"yes". (Q41474114) (← links)
• Predictive factors of [(11)C]choline PET/CT in patients with biochemical failure after radical prostatectomy (Q43276156) (← links)
• Estramustine phosphate combined with orchidectomy as first-line therapy in patients with prostate carcinoma. Effect of age on survival. (Q44098546) (← links)
• Prognostic value of DNA ploidy in prostatic cancer (Q49274135) (← links)
• Specific expression pattern of tissue cytokines analyzed through the Surface Acoustic Wave technique is associated with age-related spontaneous benign prostatic hyperplasia in rats. (Q55302098) (← links)
• Impact of competing mortality on the cancer-related mortality in localized prostate cancer (Q71576055) (← links)
• Should Medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? Part I: Framing the debate (Q71700470) (← links)
• Prostate cancer kills (Q72342529) (← links)
• Prostate cancer mortality in northern Sweden, with special reference to tumor grade and patient age (Q73279986) (← links)
• A dna cytometric proliferation index improves the value of the dna ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate (Q73707858) (← links)
• The natural history of clinical prostate carcinoma (Q73722098) (← links)
• Impact of Life Expectancy and Tumor Doubling Time on the Clinical Significance of Prostate Cancer in Japan (Q74073420) (← links)
• Age as a prognostic factor for disease recurrence after radical prostatectomy (Q78213596) (← links)
• Elevation of serum transforming growth factor-β1 Level in patients with metastatic prostate cancer (Q83169257) (← links)
• Pathological Characteristics of Prostate Cancer Occurring in Younger Men: A Retrospective Study of Prostatectomy Patients (Q90199633) (← links)
• microRNA Expression Profiling in Young Prostate Cancer Patients (Q94526757) (← links)